Tissue distribution of endralazine and its clinical effect in refractory hypertension.
D000818:Animals; D000959:Antihypertensive Agents / Q000378:metabolism* / Q000627:therapeutic use; D001345:Autoradiography; D001794:Blood Pressure / Q000187:drug effects; D002250:Carbon Radioisotopes; D003000:Clonidine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D006977:Hypertension, Renal / Q000188:drug therapy; D008297:Male; D051379:Mice; D011247:Pregnancy; D011446:Prospective Studies; D011724:Pyridazines / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D014018:Tissue Distribution
D000959:Antihypertensive Agents; D002250:Carbon Radioisotopes; D011724:Pyridazines; C014926:BQ 22-708; D003000:Clonidine